LMRI vs INSP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LMRI · Lumexa Imaging$14.26 ▲ 1.42%
INSP · Inspire Medical Systems$55.10 ▼ 2.10%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LMRI -23.0%
- INSP -59.9%
Head to head
| Metric | LMRI | INSP |
|---|---|---|
| Price | $14.26 | $55.10 |
| Change today | ▲ 1.42% | ▼ 2.10% |
| Market cap | $1.37B | $1.60B |
| Return, 3 months | +20.3% | -10.4% |
| Return, year to date | -22.9% | -40.3% |
| Return, 1 year | – | -38.7% |
| P/E (TTM) | – | 16.4 |
| P/B | 2.2 | 1.9 |
| P/E percentile vs own 5y | 1st | 69th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +5.0% | -7.9% |
| Net profit growth (YoY) | +305.0% | -345.6% |
| Gross margin | 15.4% | 86.2% |
| Operating margin | 0.7% | 1.8% |
| Net margin | -1.6% | 11.4% |
| Return on equity | -4.3% | 13.5% |
| Analyst target vs. price | +19.2% | +35.0% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 63 | 27 |
| 30-day volatility | 69.2% | 46.5% |
| Max drawdown, 1 year | -63.5% | -72.2% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- INSP is the largest of the group by market value.
- LMRI is growing revenue fastest.
- INSP keeps the most profit per dollar of sales.
- INSP has been the calmest stock over the last 30 days.